Pen Needles Market Key Players and Forecast by 2025

Published Report - Pen Needles Market to 2025 - Global Analysis and Forecasts By Type (Standard and Safety), Therapy (Insulin, GLP-1, and Growth Hormone), Length (4mm, 5mm, 6mm, 8mm,10mm, and 12mm) and Geography

Historic Data: 2015-2016 | Base Year: 2017 | Forecast Period: 2018-2025
  • Status : Published
  • Report Code : TIPAR100000824
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : June 11, 2024
Pen Needles Market Key Players and Forecast by 2025
Report Date: June 11, 2024   |   Report Code: TIPAR100000824 Email: sales@theinsightpartners.com

2017 Market Size

US$ 1.6 Bn

Base year value

2025 Forecast

US$ 2.28 Bn

Projected by 2025

CAGR 2018-2025

4.6 %

Growth rate

Addressable Market

US$ 15.75 Bn

(2018-2025)

The global pen needles market estimated to grow at a CAGR of 4.6% during the forecast period from 2018 to 2025. The market for Pen needles was valued at USD 1,603.8 Mn in 2017 and is estimated to reach US$ 2,280.6 Mn by 2025.

The global pen needles market is segmented on the basis of type, therapy, and length and geography. On the basis of type, the market is segmented into standard pen needles and safety pen needles. On the basis of therapy, the market is segmented into insulin therapy, GLP-1 therapy and growth hormone therapy. Based on length, the global pen needles market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Published Report - Pen Needles Market: Strategic Insights

global-pen-needles-report
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

The pen needles market is aimed to describe, define and estimate the forecast for market size of the pen needles till 2025. The report strategically analyzes macro and micro-markets to entail the major factors impacting the growth of the global pen needles market. The market report for pen needles is appropriate to cater the needs and demands of various stakeholders that include manufacturers, distributors and suppliers of pen needles, public and private hospitals, academic medical centers and teaching hospitals, privately practicing physicians and surgeons, medical institutes, research centers and other academic hostilities, pharmacies, ambulatory surgical centers and other distribution channels.

Europe is expected to be the dominant region in the global pen needles market. This dominance is primarily driven by the increasing Prevalence of diabetes is increasing among all ages in the European Region, majorly due to increase in overweight & obesity, unhealthy diet and physical inactivity.

According to the International Diabetes Federation (IDF) Europe, in 2017, there were 7.476.800 cases of diabetes in Germany. Moreover, approximately 270,000 new cases are recorded in Germany each year. This is expected to drive the market for overall pen needles in this country. On the other hand, Asia Pacific is expected to witness significant growth in the market owing to factors such as increasing focus of market players developing novel products at affordable prices, developing healthcare infrastructure and massive pool of diabetic prevalent population.

Pen Needles

Published Report - Pen Needles Market Report Scope

Report Attribute Details
Market size in 2017 US$ 1.6 Billion
Market Size by 2025 US$ 2.28 Billion
Global CAGR (2017 - 2025) 4.6%
Historical Data 2015-2016
Forecast period 2018-2025
Segments Covered By Type
  • Standard and Safety
By Therapy
  • Insulin
  • GLP-1
  • Growth Hormone
By Length
  • 4mm
  • 5mm
  • 6mm
  • 8mm
  • 10mm
  • 12mm
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • BD
  • Novo Nordisk A/S
  • YPSOMED AG
  • Braun Melsungen AG
  • Owen Mumford, Ltd.
  • HTL-Strefa S.A.
  • Ultimed, Inc.
  • Terumo Corporation
  • Allison Medical, Inc.
  • Artsana S.p.A.

Published Report - Pen Needles Market Players Density: Understanding Its Impact on Business Dynamics

The Published Report - Pen Needles Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

global-pen-needles-report-cagr

The major players operating in the market of pen needles include BD, Novo Nordisk A/S, YPSOMED AG, B. Braun Melsungen AG, Owen Mumford, Ltd., HTL-Strefa S.A., Ultimed, Inc., Terumo Corporation, Allison Medical, Inc., and Artsana S.p.A. among others. The global pen needles market is highly competitive and driven by large number of novel product launches and approvals. For instance, in May 2018, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of disposable syringes introduced “Dispovan” insulin pen needle which is the first made-in-India disposable pen needle that is technologically efficient and affordable than that of the currently available products in the market.

Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA